Maamoun Fatfat

816 total citations
21 papers, 588 citations indexed

About

Maamoun Fatfat is a scholar working on Toxicology, Complementary and alternative medicine and Molecular Biology. According to data from OpenAlex, Maamoun Fatfat has authored 21 papers receiving a total of 588 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Toxicology, 9 papers in Complementary and alternative medicine and 4 papers in Molecular Biology. Recurrent topics in Maamoun Fatfat's work include Bioactive Compounds and Antitumor Agents (9 papers), Nigella sativa pharmacological applications (8 papers) and Trace Elements in Health (3 papers). Maamoun Fatfat is often cited by papers focused on Bioactive Compounds and Antitumor Agents (9 papers), Nigella sativa pharmacological applications (8 papers) and Trace Elements in Health (3 papers). Maamoun Fatfat collaborates with scholars based in Lebanon, Qatar and United States. Maamoun Fatfat's co-authors include Hala Gali‐Muhtasib, Omar Nasser Rahal, Zeina Habli, Farah Ballout, Khaled Machaca, Raghida Abou Merhi, Detcho A. Stoyanovsky, Valerian E. Kagan, Hazar Haidar and Regine Schneider‐Stock and has published in prestigious journals such as Cancer Research, Molecules and Life Sciences.

In The Last Decade

Maamoun Fatfat

21 papers receiving 578 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maamoun Fatfat Lebanon 12 174 170 123 95 77 21 588
Prasanna Rajagopalan Saudi Arabia 17 232 1.3× 141 0.8× 73 0.6× 77 0.8× 65 0.8× 54 663
Chirine El‐Baba Lebanon 11 249 1.4× 252 1.5× 158 1.3× 85 0.9× 42 0.5× 15 629
Jen‐Jyh Lin Taiwan 17 376 2.2× 96 0.6× 39 0.3× 89 0.9× 58 0.8× 28 785
Ying‐Hua Luo China 16 331 1.9× 68 0.4× 122 1.0× 66 0.7× 95 1.2× 30 602
Shu‐Yi Yin Taiwan 9 220 1.3× 88 0.5× 59 0.5× 77 0.8× 36 0.5× 15 573
Benjaporn Buranrat Thailand 15 378 2.2× 62 0.4× 60 0.5× 86 0.9× 56 0.7× 82 791
V. Magesh India 13 260 1.5× 109 0.6× 57 0.5× 63 0.7× 62 0.8× 27 600
Avinaba Mukherjee India 16 352 2.0× 129 0.8× 31 0.3× 125 1.3× 90 1.2× 40 872
Abhishek Basu India 16 232 1.3× 41 0.2× 57 0.5× 103 1.1× 69 0.9× 43 838
Surya Kant Tripathi India 15 374 2.1× 45 0.3× 137 1.1× 122 1.3× 144 1.9× 34 784

Countries citing papers authored by Maamoun Fatfat

Since Specialization
Citations

This map shows the geographic impact of Maamoun Fatfat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maamoun Fatfat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maamoun Fatfat more than expected).

Fields of papers citing papers by Maamoun Fatfat

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maamoun Fatfat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maamoun Fatfat. The network helps show where Maamoun Fatfat may publish in the future.

Co-authorship network of co-authors of Maamoun Fatfat

This figure shows the co-authorship network connecting the top 25 collaborators of Maamoun Fatfat. A scholar is included among the top collaborators of Maamoun Fatfat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maamoun Fatfat. Maamoun Fatfat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hussein, Marwa, et al.. (2025). Omics technologies as powerful approaches to unravel colorectal cancer complexity and improve its management. Molecules and Cells. 48(5). 100200–100200. 1 indexed citations
2.
Fatfat, Maamoun, et al.. (2023). Thymoquinone enhances the antioxidant and anticancer activity of Lebanese propolis. World Journal of Clinical Oncology. 14(5). 203–214. 10 indexed citations
3.
Fatfat, Maamoun, et al.. (2022). Micelles as potential drug delivery systems for colorectal cancer treatment. World Journal of Gastroenterology. 28(25). 2867–2880. 29 indexed citations
4.
Fatfat, Maamoun, et al.. (2021). Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells. World Journal of Clinical Oncology. 12(7). 522–543. 25 indexed citations
5.
Fatfat, Maamoun, et al.. (2020). Thymoquinone synergizes with arsenic and interferon alpha to target human T-cell leukemia/lymphoma. Life Sciences. 251. 117639–117639. 15 indexed citations
6.
Khalil, Mahmoud, et al.. (2020). Apoptosis as a mechanism for the treatment of adult T cell leukemia: promising drugs from benchside to bedside. Drug Discovery Today. 25(7). 1189–1197. 3 indexed citations
7.
Khalil, Mahmoud, et al.. (2020). Cell Death by Gallotannin Is Associated with Inhibition of the JAK/STAT Pathway in Human Colon Cancer Cells. Current Therapeutic Research. 92. 100589–100589. 13 indexed citations
8.
Ballout, Farah, Alissar Monzer, Maamoun Fatfat, et al.. (2020). Thymoquinone induces apoptosis and DNA damage in 5-Fluorouracil-resistant colorectal cancer stem/progenitor cells. Oncotarget. 11(31). 2959–2972. 34 indexed citations
9.
10.
Ballout, Farah, Zeina Habli, Omar Nasser Rahal, Maamoun Fatfat, & Hala Gali‐Muhtasib. (2018). Thymoquinone-based nanotechnology for cancer therapy: promises and challenges. Drug Discovery Today. 23(5). 1089–1098. 54 indexed citations
11.
Ballout, Farah, et al.. (2018). Abstract 170: Targeting colorectal cancer stem cells with the anticancer molecule thymoquinone. Cancer Research. 78(13_Supplement). 170–170. 1 indexed citations
12.
Elaridi, Jomana, et al.. (2017). Preparation and biological evaluation of novel acylhydrazide derivatives of 2,3-dichloronaphthoquinone. HAL (Le Centre pour la Communication Scientifique Directe). 10(2). 122–129. 6 indexed citations
13.
Habli, Zeina, et al.. (2017). Emerging Cytotoxic Alkaloids in the Battle against Cancer: Overview of Molecular Mechanisms. Molecules. 22(2). 250–250. 109 indexed citations
14.
Bouhadir, Kamal H., et al.. (2017). Synthesis and biological assessment of novel acylhydrazone derivatives of 2-methyl-1,4-naphthoquinone. 10(4). 259–272. 5 indexed citations
15.
Rahal, Omar Nasser, et al.. (2016). Chk1 and DNA-PK mediate TPEN-induced DNA damage in a ROS dependent manner in human colon cancer cells. Cancer Biology & Therapy. 17(11). 1139–1148. 21 indexed citations
16.
Fröhlich, Tony, Julienne K. Muenzner, Christoph Reiter, et al.. (2016). Synthesis of Novel Hybrids of Thymoquinone and Artemisinin with High Activity and Selectivity Against Colon Cancer. ChemMedChem. 12(3). 226–234. 70 indexed citations
17.
Gali‐Muhtasib, Hala, et al.. (2015). Abstract 2564: The anticancer molecule TPEN induces DNA damage in human colon cancer cells. Cancer Research. 75(15_Supplement). 2564–2564. 1 indexed citations
18.
Fatfat, Maamoun, Raghida Abou Merhi, Omar Nasser Rahal, et al.. (2014). Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species. BMC Cancer. 14(1). 527–527. 90 indexed citations
19.
Naja, Farah, Lara Nasreddine, Nahla Hwalla, et al.. (2012). Association of H. pylori Infection with Insulin Resistance and Metabolic Syndrome Among Lebanese Adults. Helicobacter. 17(6). 444–451. 50 indexed citations
20.
Fatfat, Maamoun, et al.. (2008). Inclusion Complexes of 2-Chloroethylnitrososulfamides (CENS) in Natural and Modified β – Cyclodextrins. Letters in Organic Chemistry. 6(1). 37–40. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prasanna Rajagopalan Breakdown of academic impact, for papers by Chirine El‐Baba Breakdown of academic impact, for papers by Jen‐Jyh Lin Breakdown of academic impact, for papers by Ying‐Hua Luo Breakdown of academic impact, for papers by Shu‐Yi Yin Breakdown of academic impact, for papers by Benjaporn Buranrat Breakdown of academic impact, for papers by V. Magesh Breakdown of academic impact, for papers by Avinaba Mukherjee Breakdown of academic impact, for papers by Abhishek Basu Breakdown of academic impact, for papers by Surya Kant Tripathi
Rankless by CCL
2026